|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Thursday, November 24, 2016Group with Alzheimer's gene mutation exciting disease's researchers: VIDEO
60
Minutes correspondent Lesley Stahl with members of the Colombian
family CBS NEWS
Extended
family in Colombia with a genetic mutation causing Alzheimer's may
help scientists prevent the disease someday
Scientists
are hoping volunteers from the world’s largest concentration of
people with a rare genetic mutation causing Alzheimer’s
may help prevent the disease in others someday. Lesley Stahl goes to
Medellin, Colombia, to meet with members of a large extended
family, many of whom carry the gene mutation that amounts to an early
death sentence, for a 60 Minutes report to be broadcast Sunday, Nov.
27 at 7:30 p.m. ET and 7 p.m. PT.
Stahl’s
report tells the story of how a young doctor and nurse in Colombia
unraveled the mystery of a rash of patients who were coming down with
Alzheimer’s disease in their mid-40s -- figuring out that they were
part of one large, extended family, connected generations back. All
of them lived in Antioquia, a Colombian region whose capital is
Medellin. The doctor reached out to Dr. Ken Kosik, then a
Harvard professor lecturing in Bogota, who realized the significance
of the discovery. “When we looked at the family trees, about 50
percent of the offspring were getting the disease. That’s a clear
signature of a gene,” says Kosik.
A
simple genetic test could reveal which members of the family had the
gene mutation that would guarantee they would get early-onset
Alzheimer’s. This gave researchers a unique opportunity to
test therapies on persons who were certain to develop the disease,
years before they showed any symptoms -- a rare window to see whether
a treatment might be able to prevent Alzheimer’s. The nonprofit
Banner Alzheimer’s Institute in Phoenix teamed up with the National
Institutes of Health, philanthropists, and the drug company Genentech
to start a multimillion dollar clinical trial to test an
immunotherapy drug to remove amyloid plaque, a substance that builds
up in the brain of Alzheimer’s patients years before they start
getting sick.
Story
Source: The above story is based on materials provided by CBSNEWS
Note:
Materials may be edited for content and length
Labels: Video |